Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach
Ziyad Tariq Muhseen, Alaa R. Hameed, Halah M. H. Al-Hasani, et al.
Journal of Molecular Liquids (2020) Vol. 320, pp. 114493-114493
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Identification of potential plant bioactive as SARS-CoV-2 Spike protein and human ACE2 fusion inhibitors
Rahul Singh, Vijay Kumar Bhardwaj, Jatin Sharma, et al.
Computers in Biology and Medicine (2021) Vol. 136, pp. 104631-104631
Open Access | Times Cited: 96
An update review of emerging small-molecule therapeutic options for COVID-19
Dengke Tian, Yuzhi Liu, Chengyuan Liang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111313-111313
Open Access | Times Cited: 62
A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19
Essa M. Saied, Yousra A. El‐Maradny, Alaa A. Osman, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1759-1759
Open Access | Times Cited: 58
Quality analysis and authentication of nutraceuticals using near IR (NIR) spectroscopy: A comprehensive review of novel trends and applications
Maii M. Nagy, Shengpeng Wang, Mohamed A. Farag
Trends in Food Science & Technology (2022) Vol. 123, pp. 290-309
Closed Access | Times Cited: 52
Identification of Small Molecule Inhibitors of the Deubiquitinating Activity of the SARS-CoV-2 Papain-Like Protease: in silico Molecular Docking Studies and in vitro Enzymatic Activity Assay
Eleni Pitsillou, Julia Liang, Katherine Ververis, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 58
Plant Products as Inhibitors of Coronavirus 3CL Protease
Anirban Mandal, Ajeet Kumar Jha, Banasri Hazra
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 55
Pinpointing the potential hits for hindering interaction of SARS-CoV-2 S-protein with ACE2 from the pool of antiviral phytochemicals utilizing molecular docking and molecular dynamics (MD) simulations
Chirag Patel, Dweipayan Goswami, Dharmesh G. Jaiswal, et al.
Journal of Molecular Graphics and Modelling (2021) Vol. 105, pp. 107874-107874
Open Access | Times Cited: 51
Cheminformatics-Based Identification of Potential Novel Anti-SARS-CoV-2 Natural Compounds of African Origin
Samuel K. Kwofie, Emmanuel Broni, Seth O. Asiedu, et al.
Molecules (2021) Vol. 26, Iss. 2, pp. 406-406
Open Access | Times Cited: 46
siRNA Therapeutics for the Therapy of COVID-19 and Other Coronaviruses
Muhammad Imran Sajid, Muhammad Moazzam, Yeseom Cho, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 6, pp. 2105-2121
Open Access | Times Cited: 43
Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents
Jie Mei, Yatong Zhou, Xinping Yang, et al.
Journal of Ethnopharmacology (2021) Vol. 278, pp. 114303-114303
Open Access | Times Cited: 42
Role of dietary supplements in the continuous battle against COVID‐19
Rahela Zaman, Vignesh Ravichandran, Chung Keat Tan
Phytotherapy Research (2024) Vol. 38, Iss. 2, pp. 1071-1088
Closed Access | Times Cited: 7
Modeling and simulations of CoViD-19 molecular mechanism induced by cytokines storm during SARS-CoV2 infection
Zhenhua Yu, R. Ellahi, Alessandro Nutini, et al.
Journal of Molecular Liquids (2020) Vol. 327, pp. 114863-114863
Open Access | Times Cited: 49
Discovery of anti-MERS-CoV small covalent inhibitors through pharmacophore modeling, covalent docking and molecular dynamics simulation
Mubarak A. Alamri, Muhammad Tahir ul Qamar, Obaid Afzal, et al.
Journal of Molecular Liquids (2021) Vol. 330, pp. 115699-115699
Open Access | Times Cited: 40
Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19
Rajeshwari Singh, Sumeet Goel, Pascale Bourgeade, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 40, pp. 55925-55951
Open Access | Times Cited: 36
Identification of antiviral phytochemicals as a potential SARS-CoV-2 main protease (Mpro) inhibitor using docking and molecular dynamics simulations
Chirag Patel, Siddhi P. Jani, Dharmesh G. Jaiswal, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 34
Glycyrrhizin as a promising kryptonite against SARS-CoV-2: Clinical, experimental, and theoretical evidences
Suvankar Banerjee, Sandip Kumar Baidya, Nilanjan Adhikari, et al.
Journal of Molecular Structure (2022) Vol. 1275, pp. 134642-134642
Open Access | Times Cited: 25
Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2
Ziyad Tariq Muhseen, Alaa R. Hameed, Halah M. H. Al-Hasani, et al.
Molecules (2021) Vol. 26, Iss. 3, pp. 674-674
Open Access | Times Cited: 30
Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets
Isabella Romeo, Francesco Mesiti, Antonio Lupia, et al.
Molecules (2021) Vol. 26, Iss. 3, pp. 632-632
Open Access | Times Cited: 28
Development and application of ribonucleic acid therapy strategies against COVID-19
Lin Ning, Mujiexin Liu, Yushu Gou, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 13, pp. 5070-5085
Open Access | Times Cited: 22
New AKT-dependent mechanisms of anti-COVID-19 action of high-CBD Cannabis sativa extracts
Bo Wang, Dongping Li, Anna Fiselier, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 20
RETRACTED ARTICLE: Multifaceted role of natural sources for COVID-19 pandemic as marine drugs
Md. Mominur Rahman, Md. Rezaul Islam, Sheikh Shohag, et al.
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 31, pp. 46527-46550
Open Access | Times Cited: 20
Harnessing Plant Arsenal to Struggle with SARS-CoV-2: Approaches and Challenges
Latifa Khattabi
(2025), pp. 267-305
Closed Access
SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibility
Mariana Valério, Luís Borges-Araújo, Manuel N. Melo, et al.
Frontiers in Medical Technology (2022) Vol. 4
Open Access | Times Cited: 17
Integrated virtual screening and molecular dynamics simulation approaches revealed potential natural inhibitors for DNMT1 as therapeutic solution for triple negative breast cancer
Yasir Bashir, Fatima Noor, Sajjad Ahmad, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 3, pp. 1099-1109
Open Access | Times Cited: 10
In Silico and In Vitro Analyses of Multiple Terpenes Predict Cryptotanshinone as a Potent Inhibitor of the Omicron Variant of SARS-CoV-2
Asmita Shrestha, Siddha Raj Upadhyaya, Bimal Kumar Raut, et al.
Processes (2024) Vol. 12, Iss. 1, pp. 230-230
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top